Drug intelligence / Profile preview

esflurbiprofen

Development stage
Phase 3
Lead developer
Teikoku Seiyaku
Modality
Small Molecules
Administration
Topical, Transdermal
01

Overview

Esflurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) and the S-enantiomer of flurbiprofen, developed as a topical treatment for pain and inflammation associated with osteoarthritis and other musculoskeletal disorders. It works by inhibiting cyclooxygenase (COX), an enzyme responsible for the synthesis of prostaglandins that mediate pain, fever, and inflammation. Esflurbiprofen is formulated primarily as patches or topical preparations to deliver high concentrations directly to affected tissues. Clinical studies have demonstrated its efficacy in reducing joint pain and inflammation in conditions such as knee osteoarthritis, soft tissue injuries, and ankle sprains[1][2][5][6][7].

Brand names
LOQOA TapeLocoa
Other names
S-flurbiprofenS-enantiomer of flurbiprofen
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on esflurbiprofen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on esflurbiprofen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call